Related Experiment Videos
[Medical treatment of chronic congestive heart failure]
1Département de cardiologie Centre hospitalier universitaire de Nancy-Brabois 54500 Vandoeuvre-lès-Nancy. y.juillière@chu-nancy.fr
Insights
Medical treatments for congestive heart failure have advanced, with established therapies for systolic dysfunction. However, effective medications for diastolic dysfunction are still under investigation.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Congestive heart failure (CHF) management has significantly evolved over the last 15 years.
- Left ventricular systolic dysfunction (LVSD) is a primary focus of current therapeutic strategies.
Purpose:
- To review current evidence-based medical treatments for congestive heart failure.
- To highlight advancements in managing left ventricular systolic dysfunction and identify gaps in treating diastolic dysfunction.
Summary:
- Angiotensin-converting-enzyme inhibitors are confirmed for LVSD across all New York Heart Association (NYHA) classes, reducing morbidity and mortality.
- Beta-blockers are recommended for symptomatic classes, and spironolactone shows efficacy in severe NYHA classes.
- Diuretics, digoxin, and nitrates have roles in managing specific CHF symptoms and hospitalizations, but treatments for left ventricular diastolic dysfunction lack confirmed efficacy.
Impact:
- Established treatments improve outcomes for systolic heart failure.
- Further research is needed to develop effective therapies for diastolic heart failure, addressing a significant unmet clinical need.
Abstract:
Medical treatment in congestive heart failure has been largely improved during the last 15 years. Treatment of left ventricular systolic dysfunction using angiotensin-converting-enzyme inhibitor is now confirmed in all NYHA classes, due to the important reduction in morbi-mortality. Betablockers have to be systematically associated in symptomatic classes. Among other drugs, only spironolactone has been shown efficient in severe NYHA classes. Diuretics in case of congestive symptoms, digoxin in order to reduce the frequency of hospitalization, and nitrates as adding therapy in severe classes may be also prescribed. However, treatment of left ventricular diastolic dysfunction remains under debate since up to date, no medication has shown a confirmed efficacy.